(Q31391473)

1 July 2017

title

Temporal development of 2',3'-dideoxyinosine (ddI)-induced peripheral myelinopathy (English)

1 reference

1 July 2017

Patterson TA

1

1 reference

1 July 2017

Schmued LC

series ordinal

2

1 reference

1 July 2017

Sandberg JA

series ordinal

3

1 reference

1 July 2017

Slikker W

series ordinal

4

1 reference

1 July 2017

publication date

1 May 2000

1 reference

Neurotoxicology and Teratology

1 July 2017

published in

1 reference

1 July 2017

volume

22

1 reference

1 July 2017

issue

3

1 reference

1 July 2017

page(s)

429-434

1 reference

2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial

1 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2899%2900087-2

7 January 2021

Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2899%2900087-2

7 January 2021

Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2',3'-dideoxycytidine (ddC).

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2899%2900087-2

7 January 2021

2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2899%2900087-2

7 January 2021

Molecular targets for AIDS therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2899%2900087-2

7 January 2021

Pharmacokinetics of 2',3'-dideoxyinosine in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2899%2900087-2

7 January 2021

Overview of phase I trials of 2',3'-dideoxyinosine (ddI) conducted on adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2899%2900087-2

7 January 2021

Evaluation of brain and nerve pathology in rats chronically dosed with ddI or isoniazid

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2899%2900087-2

7 January 2021

Pharmacokinetics of oral 2',3'-dideoxyinosine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2899%2900087-2

7 January 2021

Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2899%2900087-2

7 January 2021

The National Cancer Institute phase I study of 2',3'-dideoxyinosine administration in adults with AIDS or AIDS-related complex: analysis of activity and toxicity profiles

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2899%2900087-2

7 January 2021

Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0892-0362%2899%2900087-2

7 January 2021

10.1016/S0892-0362(99)00087-2

Identifiers

DOI

1 reference

1 July 2017

1 reference